SCHEMBL25724248

SCHEMBL25724248

COc1ncccc1CN(C)C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 5/20 0.41
▸ MAOA P21397 3/20 0.41
▸ MAOB P27338 2/20 0.41
▸ SLC13A5 Q86YT5 1/20 0.41
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ APLNR P35414 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ HRH1 P35367 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ CHRM2 P08172 1/20 0.37
▸ CHRM4 P08173 1/20 0.37
▸ CHRM5 P08912 1/20 0.37
▸ CHRM1 P11229 1/20 0.37
▸ CHRM3 P20309 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ MMP2 P08253 2/20 0.36
▸ MMP9 P14780 2/20 0.36
▸ MMP8 P22894 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26272332 0.82 SLC6A2 (0.45) KDM1AMAOAMAOBSLC13A5HTR2A
SCHEMBL12089063 0.78 CHRM2 (0.38) KDM1AMAOBHTR2ACYP2D6HRH1
SCHEMBL14983860 0.77 KDM1A (0.43) KDM1AMAOAMAOBSLC13A5HTR2A
SCHEMBL19465 0.77 HTR2A (0.46) KDM1AMAOAMAOBSLC13A5HTR2A
SCHEMBL12089224 0.75 LMNA (0.44) CYP2D6CHRM2CHRM4CHRM5CHRM1
SCHEMBL24225560 0.75 SLC13A5 (0.48) KDM1AMAOAMAOBSLC13A5HTR2A
SCHEMBL91503 0.74 SLC13A5 (0.50) KDM1AMAOAMAOBSLC13A5HTR2A
SCHEMBL17570342 0.74 KMT2A (0.47) ALDH1A1MEN1KMT2A
SCHEMBL25733514 0.74 SLC13A5 (0.36) SLC13A5CHRM2CHRM4CHRM5CHRM1
SCHEMBL12088736 0.74 CHRM2 (0.56) MAOBCHRM2CHRM1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114428-A1 HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF DISEASE Vir Biotechnology, Inc. (US) 2023-06-22 — — WO disclosed
Send feedback